---
category: news
title: "OpenBench and HemoShear Therapeutics Agree to Pursue Rare Disease Target Using Artificial Intelligence"
excerpt: "OpenBench, Inc., an emerging leader in AI-enabled small molecule discovery, entered into an agreement with HemoShear Therapeutics, Inc., a privately held clinical stage biotechnology company, to use the OpenBench virtual screening platform to identify novel,"
publishedDateTime: 2021-10-05T16:21:00Z
originalUrl: "https://www.uppermichiganssource.com/prnewswire/2021/10/05/openbench-hemoshear-therapeutics-agree-pursue-rare-disease-target-using-artificial-intelligence/"
webUrl: "https://www.uppermichiganssource.com/prnewswire/2021/10/05/openbench-hemoshear-therapeutics-agree-pursue-rare-disease-target-using-artificial-intelligence/"
type: article
quality: 1
heat: 1
published: false

provider:
  name: Upper
  domain: uppermichiganssource.com

topics:
  - AI

secured: "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;lWlcwbhzrNpTvvlgdULpwQ=="
---

